Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-23-006452

Options or other derivatives

  • CMO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Donovan Joanne M. · CMO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X05/primarydocument.xml…